Explainable machine-learning model for postoperative lower-extremity deep vein thrombosis after gynecologic cancer surgery.

IF 3.4 3区 医学 Q2 ONCOLOGY
Frontiers in Oncology Pub Date : 2026-09-30 eCollection Date: 2026-01-01 DOI:10.3389/fonc.2026.1813354
Yanhong Zhang, Congcong Shi, Deyan Yang, Xiaona Ji, Yingli Chu
{"title":"Explainable machine-learning model for postoperative lower-extremity deep vein thrombosis after gynecologic cancer surgery.","authors":"Yanhong Zhang, Congcong Shi, Deyan Yang, Xiaona Ji, Yingli Chu","doi":"10.3389/fonc.2026.1813354","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Postoperative lower-extremity deep vein thrombosis (DVT) is a common and potentially fatal complication after radical surgery for gynecologic malignancies, yet population-specific risk tools remain limited.</p><p><strong>Methods: </strong>We retrospectively analyzed 500 consecutive patients who underwent radical surgery for cervical, endometrial, or ovarian cancer (January 2022-January 2025). The cohort was randomly divided into a training set (n=351, 70%) and a validation set (n=149, 30%) at a 7:3 ratio. Independent predictors were identified using logistic regression, and 10 machine-learning algorithms were trained and compared. Model discrimination, calibration, and clinical utility were evaluated, and the optimal model was interpreted using SHAP.</p><p><strong>Results: </strong>DVT occurred in 116 patients (23.2%). Five variables were independently associated with DVT: age, Caprini score, lymphocyte count, preoperative D-dimer, and neutrophil-to-lymphocyte ratio (NLR).Across candidate models, CatBoost achieved the optimal overall performance on the validation set, yielding an AUC of 0.816 (95% CI: 0.738-0.881), with sensitivity of 0.824 (95% CI: 0.700-1.000) and specificity of 0.730 (95% CI: 0.515-0.876), and SHAP analysis ranked the predictors by mean absolute SHAP value in the following order: lymphocyte count, Caprini score, age, preoperative D-dimer, and neutrophil-to-lymphocyte ratio (NLR).</p><p><strong>Conclusion: </strong>An interpretable CatBoost-based model enables individualized postoperative DVT risk stratification after gynecologic cancer surgery and may support targeted, evidence-based thromboprophylaxis and perioperative nursing management.</p>","PeriodicalId":12482,"journal":{"name":"Frontiers in Oncology","volume":"16 ","pages":"1813354"},"PeriodicalIF":3.4000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13661352/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fonc.2026.1813354","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Postoperative lower-extremity deep vein thrombosis (DVT) is a common and potentially fatal complication after radical surgery for gynecologic malignancies, yet population-specific risk tools remain limited.

Methods: We retrospectively analyzed 500 consecutive patients who underwent radical surgery for cervical, endometrial, or ovarian cancer (January 2022-January 2025). The cohort was randomly divided into a training set (n=351, 70%) and a validation set (n=149, 30%) at a 7:3 ratio. Independent predictors were identified using logistic regression, and 10 machine-learning algorithms were trained and compared. Model discrimination, calibration, and clinical utility were evaluated, and the optimal model was interpreted using SHAP.

Results: DVT occurred in 116 patients (23.2%). Five variables were independently associated with DVT: age, Caprini score, lymphocyte count, preoperative D-dimer, and neutrophil-to-lymphocyte ratio (NLR).Across candidate models, CatBoost achieved the optimal overall performance on the validation set, yielding an AUC of 0.816 (95% CI: 0.738-0.881), with sensitivity of 0.824 (95% CI: 0.700-1.000) and specificity of 0.730 (95% CI: 0.515-0.876), and SHAP analysis ranked the predictors by mean absolute SHAP value in the following order: lymphocyte count, Caprini score, age, preoperative D-dimer, and neutrophil-to-lymphocyte ratio (NLR).

Conclusion: An interpretable CatBoost-based model enables individualized postoperative DVT risk stratification after gynecologic cancer surgery and may support targeted, evidence-based thromboprophylaxis and perioperative nursing management.

妇科癌症手术后下肢深静脉血栓形成的可解释机器学习模型。
背景:术后下肢深静脉血栓形成(DVT)是妇科恶性肿瘤根治性手术后常见且可能致命的并发症,但针对特定人群的风险工具仍然有限。方法:我们回顾性分析了500例连续接受宫颈癌、子宫内膜癌或卵巢癌根治性手术的患者(2022年1月- 2025年1月)。队列按7:3的比例随机分为训练集(n= 351,70%)和验证集(n= 149,30%)。使用逻辑回归确定独立预测因子,并对10种机器学习算法进行训练和比较。评估模型判别、校准和临床效用,并使用SHAP对最佳模型进行解释。结果:发生深静脉血栓116例(23.2%)。5个变量与DVT独立相关:年龄、capryini评分、淋巴细胞计数、术前d -二聚体和中性粒细胞与淋巴细胞比值(NLR)。在候选模型中,CatBoost在验证集上获得了最佳的总体性能,AUC为0.816 (95% CI: 0.738-0.881),灵敏度为0.824 (95% CI: 0.700-1.000),特异性为0.730 (95% CI: 0.515-0.876), SHAP分析根据SHAP均值绝对值对预测因子进行排序,顺序为:淋巴细胞计数、Caprini评分、年龄、术前d -二聚体和中性粒细胞与淋巴细胞比率(NLR)。结论:一个可解释的基于catboost的模型可以实现妇科癌症手术后DVT风险的个体化分层,并可能支持有针对性的、循证的血栓预防和围手术期护理管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Oncology
Frontiers in Oncology Biochemistry, Genetics and Molecular Biology-Cancer Research
CiteScore
6.20
自引率
10.60%
发文量
6641
审稿时长
14 weeks
期刊介绍: Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书